Publications by authors named "John Foss"

Claim this Profile
O
Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity activation of guanylate cyclase-C in rat models.
Illona-Marie Boulete, Anusha Thadi, Catherine Beaufrand, Viren Patwa, Apoorva Joshi, John A Foss

World J Gastroenterol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.
Kunwar Shailubhai, Vaseem Palejwala, Krishna Priya Arjunan, Sayali Saykhedkar, Bradley Nefsky, John A Foss

World J Gastrointest Pharmacol Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.
Kunwar Shailubhai, Stephen Comiskey, John A Foss, Rong Feng, Laura Barrow

Dig Dis Sci· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral gavage subchronic neurotoxicity and inhalation subchronic immunotoxicity studies of ethylbenzene in the rat.
Abby A Li, Jacques P J Maurissen, John F Barnett, John Foss, Les Freshwater

Neurotoxicology· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Kevin M Crofton, John A Foss, Ulla Hass, Karl F Jensen, Edward D Levin

Neurotoxicol Teratol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis